PortfoliosLab logo

BioPlus Acquisition Corp. Unit (BIOSU)

Equity · Currency in USD · Last updated Mar 26, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in BioPlus Acquisition Corp. Unit in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $10,460 for a total return of roughly 4.60%. All prices are adjusted for splits and dividends.


-20.00%-15.00%-10.00%-5.00%0.00%5.00%NovemberDecember2023FebruaryMarch
4.60%
-13.24%
BIOSU (BioPlus Acquisition Corp. Unit)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BIOSU

BioPlus Acquisition Corp. Unit

Return

BioPlus Acquisition Corp. Unit had a return of 2.55% year-to-date (YTD) and 4.81% in the last 12 months. Over the past 10 years, BioPlus Acquisition Corp. Unit had an annualized return of 3.52%, while the S&P 500 had an annualized return of -10.34%, indicating that BioPlus Acquisition Corp. Unit did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month0.58%-0.66%
Year-To-Date2.55%3.42%
6 months4.70%5.67%
1 year4.81%-10.89%
5 years (annualized)3.52%-10.34%
10 years (annualized)3.52%-10.34%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20231.18%0.78%
20220.00%0.60%0.89%-0.00%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current BioPlus Acquisition Corp. Unit Sharpe ratio is 1.84. A Sharpe ratio greater than 1.0 is considered acceptable.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.001.502.00Dec 11Dec 18Dec 252023Jan 08Jan 15Jan 22Jan 29Feb 05Feb 12Feb 19Feb 26Mar 05Mar 12Mar 19
1.84
-0.47
BIOSU (BioPlus Acquisition Corp. Unit)
Benchmark (^GSPC)

Dividend History


BioPlus Acquisition Corp. Unit doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2023FebruaryMarch0
-17.21%
BIOSU (BioPlus Acquisition Corp. Unit)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the BioPlus Acquisition Corp. Unit. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the BioPlus Acquisition Corp. Unit is 1.39%, recorded on Feb 24, 2022. It took 147 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-1.39%Dec 14, 202150Feb 24, 2022147Sep 26, 2022197
-0.4%Sep 27, 20221Sep 27, 202216Oct 19, 202217
-0.29%Jan 18, 20231Jan 18, 20238Jan 30, 20239
-0.29%Feb 15, 20231Feb 15, 20239Mar 1, 202310
-0.2%Dec 10, 20211Dec 10, 20211Dec 13, 20212
-0.19%Jan 11, 20231Jan 11, 20231Jan 12, 20232
-0.19%Feb 3, 20231Feb 3, 20231Feb 6, 20232
-0.1%Dec 7, 20211Dec 7, 20211Dec 8, 20212
-0.1%Nov 16, 20221Nov 16, 20227Nov 28, 20228
-0.1%Dec 8, 20221Dec 8, 20221Dec 9, 20222

Volatility Chart

Current BioPlus Acquisition Corp. Unit volatility is 1.01%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%10.00%20.00%30.00%40.00%NovemberDecember2023FebruaryMarch
1.01%
19.50%
BIOSU (BioPlus Acquisition Corp. Unit)
Benchmark (^GSPC)